{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:48:41Z","timestamp":1787064521497,"version":"build-2736575974"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.smim.2021.101521","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T22:10:50Z","timestamp":1636409450000},"page":"101521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cellular and molecular diversity in spondyloarthritis"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4326-4834","authenticated-orcid":false,"given":"G.R.","family":"Gulino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-7021","authenticated-orcid":false,"given":"M.","family":"Van Mechelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5986-3092","authenticated-orcid":false,"given":"R.","family":"Lories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2021.101521_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaut.2014.01.015","article-title":"The classification and diagnostic criteria of ankylosing spondylitis","volume":"48-49","author":"Raychaudhuri","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.smim.2021.101521_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.smim.2021.101521_bib0015","first-page":"2095","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7809","key":"10.1016\/j.smim.2021.101521_bib0020","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A 27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.smim.2021.101521_bib0025","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/art.24599","article-title":"Spondylarthritis in HLA-B27\/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8","volume":"60","author":"Taurog","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0030","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.167.5.2619","article-title":"The recognition of HLA-B27 by human CD4(+) T lymphocytes","volume":"167","author":"Boyle","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2021.101521_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","article-title":"Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging","volume":"59","author":"Bollow","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.60.4.316","article-title":"Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis","volume":"60","author":"Laloux","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/ar386","article-title":"Circulating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitis","volume":"4","author":"Schirmer","year":"2002","journal-title":"Arthritis Res."},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0050","doi-asserted-by":"crossref","first-page":"R292","DOI":"10.1186\/ar793","article-title":"Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis","volume":"5","author":"Duftner","year":"2003","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.smim.2021.101521_bib0055","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2008.088120","article-title":"Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls","volume":"68","author":"Zhang","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.smim.2021.101521_bib0060","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.27699","article-title":"Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response","volume":"62","author":"Ciccia","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3892\/etm.2014.2046","article-title":"T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis","volume":"9","author":"Wang","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0070","first-page":"428","article-title":"Altered cytotoxicity profile of CD8+ T cells in ankylosing spondylitis","volume":"72","author":"Gracey","year":"2020","journal-title":"."},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0075","first-page":"1272","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"."},{"issue":"11","key":"10.1016\/j.smim.2021.101521_bib0080","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2019-215349","article-title":"Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis","volume":"78","author":"Qaiyum","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0085","first-page":"435","article-title":"Polyfunctional, proinflammatory, tissue-resident memory phenotype and function of synovial Interleukin-17A+CD8+ T cells in psoriatic arthritis","volume":"72","author":"Steel","year":"2020","journal-title":"."},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0090","first-page":"679","article-title":"Sexual dimorphism in the Th17 signature of ankylosing spondylitis","volume":"68","author":"Gracey","year":"2016","journal-title":"."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/keu382","article-title":"IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities","volume":"54","author":"Jansen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.smim.2021.101521_bib0100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/rheumatology\/kes267","article-title":"Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27+ patients","volume":"52","author":"Bautista-Caro","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.smim.2021.101521_bib0105","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/808724","article-title":"Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy","volume":"2012","author":"Szalay","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10875-012-9774-0","article-title":"Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-\u03b1 therapy","volume":"33","author":"Xueyi","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0115","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3899\/jrheum.110862","article-title":"In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis","volume":"39","author":"Limon-Camacho","year":"2012","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.semarthrit.2019.04.007","article-title":"Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases(\u2730)","volume":"48","author":"Tanaka","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.smim.2021.101521_bib0125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/apm.12994","article-title":"Anti-tumor necrosis factor treatment increases both the Th17 and Th22 T helper subsets in spondyloarthritis","volume":"127","author":"Andersen","year":"2019","journal-title":"Apmis"},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000484250","article-title":"The impact of Anti-TNF therapy on CD4+ and CD8+ cell subsets in ankylosing spondylitis","volume":"85","author":"Dulic","year":"2018","journal-title":"Pathobiology"},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.berh.2016.02.002","article-title":"New immune cells in spondyloarthritis: key players or innocent bystanders?","volume":"29","author":"Venken","year":"2015","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1744-313X.2007.00739.x","article-title":"Killer cell immunoglobulin-like receptors on NK cells: the how, where and why","volume":"35","author":"Gardiner","year":"2008","journal-title":"Int. J. Immunogenet."},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0145","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/cmi.2010.42","article-title":"Contribution of functional KIR3DL1 to ankylosing spondylitis","volume":"7","author":"Zvyagin","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2021.101521_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008906","article-title":"Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis","volume":"16","author":"Hanson","year":"2020","journal-title":"PLoS Genet."},{"issue":"11","key":"10.1016\/j.smim.2021.101521_bib0155","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1002\/art.21395","article-title":"Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis","volume":"52","author":"Chan","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0160","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","article-title":"Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis","volume":"186","author":"Bowness","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0165","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/annrheumdis-2013-203881","article-title":"Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-\u03b1 production by interaction with its soluble E-cadherin ligand in chronically inflamed joints","volume":"73","author":"Melis","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101521_bib0170","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1058738","article-title":"The proportion of regulatory T cells in patients with ankylosing spondylitis: a meta-analysis","volume":"2019","author":"Lai","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0175","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.smim.2021.101521_bib0180","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3899\/jrheum.110377","article-title":"Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis","volume":"38","author":"Appel","year":"2011","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0185","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-3083.2006.001755.x","article-title":"FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints","volume":"63","author":"Cao","year":"2006","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0190","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1177\/147323001103900543","article-title":"Inverse correlation between CD4+ CD25high CD127low\/- regulatory T-cells and serum immunoglobulin A in patients with new-onset ankylosing spondylitis","volume":"39","author":"Zhao","year":"2011","journal-title":"J. Int. Med. Res."},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/icb.2015.90","article-title":"TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO","volume":"94","author":"Ye","year":"2016","journal-title":"Immunol. Cell Biol."},{"issue":"8","key":"10.1016\/j.smim.2021.101521_bib0200","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.autrev.2016.06.001","article-title":"Detection of novel diagnostic antibodies in ankylosing spondylitis: an overview","volume":"15","author":"Quaden","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"18\u201319","key":"10.1016\/j.smim.2021.101521_bib0205","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.lfs.2013.09.003","article-title":"Peripheral B-cell activation and exhaustion markers in patients with ankylosing spondylitis","volume":"93","author":"Niu","year":"2013","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0210","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","article-title":"Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial","volume":"62","author":"Song","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.semarthrit.2020.12.002","article-title":"Anti-CD74 antibodies in spondyloarthritis: a systematic review and meta-analysis","volume":"51","author":"Xu","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0220","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/annrheumdis-2012-202208","article-title":"Autoantibodies against CD74 in spondyloarthritis","volume":"73","author":"Baerlecken","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.smim.2021.101521_bib0225","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/art.23078","article-title":"Histopathologic changes at \u201csynovio-entheseal complexes\u201d suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis","volume":"56","author":"Benjamin","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.smim.2021.101521_bib0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/BOR.0000000000000254","article-title":"Microtrauma: no longer to be ignored in spondyloarthritis?","volume":"28","author":"Van Mechelen","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.smim.2021.101521_bib0235","first-page":"1816","article-title":"Brief report: group 3 innate lymphoid cells in human enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0240","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/BOR.0b013e3283620163","article-title":"The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis","volume":"25","author":"Al-Mossawi","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41467-018-07911-6","article-title":"ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in Spondyloarthritis patients","volume":"10","author":"Venken","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.smim.2021.101521_bib0250","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0255","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/art.27324","article-title":"Invariant natural killer T cells are natural regulators of murine spondylarthritis","volume":"62","author":"Jacques","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0260","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.4049\/jimmunol.179.4.2300","article-title":"A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner","volume":"179","author":"Coppieters","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2021.101521_bib0265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2009.261","article-title":"Invariant natural killer T cells in rheumatic disease: a joint dilemma","volume":"6","author":"Drennan","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-015-0507-2","article-title":"IL-23 responsive innate-like T cells in spondyloarthritis: the less frequent they are, the more vital they appear","volume":"17","author":"Venken","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.smim.2021.101521_bib0275","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3389\/fimmu.2018.01610","article-title":"Increased IL-22- and IL-17A-producing mucosal-associated invariant T cells in the peripheral blood of patients with ankylosing spondylitis","volume":"9","author":"Toussirot","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2021.101521_bib0280","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3899\/jrheum.151133","article-title":"Involvement of mucosal-associated invariant T cells in ankylosing spondylitis","volume":"43","author":"Hayashi","year":"2016","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.smim.2021.101521_bib0285","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0090-1229(91)90090-W","article-title":"Gamma\/delta T cells and their subpopulations in blood and synovial fluid from rheumatoid arthritis and spondyloarthritis","volume":"59","author":"Meliconi","year":"1991","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.smim.2021.101521_bib0295","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.12659\/MSM.897126","article-title":"Assay of Peripheral Regulatory V\u03b41 T Cells in Ankylosing Spondylitis and its Significance","volume":"22","author":"Wang","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0300","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","article-title":"Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis","volume":"64","author":"Kenna","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"7534","key":"10.1016\/j.smim.2021.101521_bib0305","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.smim.2021.101521_bib0310","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.autrev.2011.04.017","article-title":"Emerging role for NK cells in the pathogenesis of inflammatory arthropathies","volume":"10","author":"Conigliaro","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2005.10.011","article-title":"Natural killer cells in human health and disease","volume":"118","author":"Orange","year":"2006","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0320","first-page":"193","article-title":"Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients","volume":"8","author":"Mousavi","year":"2009","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0325","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13075-018-1692-y","article-title":"An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus","volume":"20","author":"Schulte-Wrede","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0330","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nrrheum.2016.218","article-title":"Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases","volume":"13","author":"Shikhagaie","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0335","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/art.34355","article-title":"Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis","volume":"64","author":"Ciccia","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.smim.2021.101521_bib0340","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.smim.2021.101521_bib0345","first-page":"1085","article-title":"Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis","volume":"34","author":"Triggianese","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7230","key":"10.1016\/j.smim.2021.101521_bib0350","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0355","first-page":"392","article-title":"Expansion of Interleukin-22- and granulocyte-macrophage colony-stimulating factor-expressing, but not Interleukin-17A-expressing, group 3 innate lymphoid cells in the inflamed joints of patients with spondyloarthritis","volume":"71","author":"Blijdorp","year":"2019","journal-title":"."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0360","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/s41467-017-01771-2","article-title":"Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis","volume":"8","author":"Al-Mossawi","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-020-2115-4","article-title":"Innate lymphoid cells in inflammatory arthritis","volume":"22","author":"Fang","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2021.101521_bib0370","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fmicb.2014.00006","article-title":"Blood dendritic cells: \u201ccanary in the coal mine\u201d to predict chronic inflammatory disease?","volume":"5","author":"Miles","year":"2014","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.smim.2021.101521_bib0375","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.24023","article-title":"Correlation between dendritic cell functional defect and spondylarthritis phenotypes in HLA-B27\/HUMAN beta2-microglobulin-transgenic rat lines","volume":"58","author":"Fert","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.smim.2021.101521_bib0380","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/art.34561","article-title":"Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis","volume":"64","author":"Utriainen","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0385","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kev245","article-title":"Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation","volume":"55","author":"Wright","year":"2016","journal-title":"Rheumatology Oxford (Oxford)"},{"issue":"5","key":"10.1016\/j.smim.2021.101521_bib0390","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10067-018-4388-4","article-title":"Dendritic cells in the pathogenesis of ankylosing spondylitis and axial spondyloarthritis","volume":"38","author":"Slobodin","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.smim.2021.101521_bib0395","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.24780","article-title":"Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability","volume":"60","author":"Dhaenens","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0400","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13075-014-0417-0","article-title":"Monocyte-derived dendritic cells from HLA-B27+ axial spondyloarthritis (SpA) patients display altered functional capacity and deregulated gene expression","volume":"16","author":"Talpin","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.smim.2021.101521_bib0405","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/rheumatology\/keh115","article-title":"Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid","volume":"43","author":"Van Krinks","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"6335","key":"10.1016\/j.smim.2021.101521_bib0410","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2021.101521_bib0415","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cellimm.2014.05.010","article-title":"Monocyte homeostasis and the plasticity of inflammatory monocytes","volume":"291","author":"Mitchell","year":"2014","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2021.101521_bib0420","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3899\/jrheum.130803","article-title":"Blood monocyte heterogeneity and markers of endothelial activation in ankylosing spondylitis","volume":"41","author":"Surdacki","year":"2014","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2021.101521_bib0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020291","article-title":"TNF-\u03b1 inhibitors decrease classical CD14(hi)CD16- monocyte subsets in highly active, conventional treatment refractory rheumatoid arthritis and ankylosing spondylitis","volume":"20","author":"Batko","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.smim.2021.101521_bib0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144655","article-title":"Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis","volume":"10","author":"Perpetuo","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.smim.2021.101521_bib0435","first-page":"2003","article-title":"Proinflammatory CX3CR1+CD59+tumor necrosis factor-like molecule 1A+interleukin-23+ monocytes are expanded in patients with ankylosing spondylitis and modulate innate lymphoid cell 3 immune functions","volume":"70","author":"Ciccia","year":"2018","journal-title":"."},{"issue":"8","key":"10.1016\/j.smim.2021.101521_bib0440","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20140678","article-title":"CX\u2083CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22","volume":"211","author":"Longman","year":"2014","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.smim.2021.101521_bib0445","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1136\/ard.2008.097204","article-title":"Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway","volume":"68","author":"Wright","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.smim.2021.101521_bib0450","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-017-0291-2","article-title":"Autoantibodies to osteoprotegerin are associated with low hip bone mineral density and history of fractures in axial spondyloarthritis: a cross-sectional observational study","author":"Hauser","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"7","key":"10.1016\/j.smim.2021.101521_bib0455","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2018-214944","article-title":"Identification of myeloid cells in the human enthesis as the main source of local IL-23 production","volume":"78","author":"Bridgewood","year":"2019","journal-title":"Ann. Rheum. Dis."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453232100052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453232100052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:23:37Z","timestamp":1760916217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104453232100052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":91,"alternative-id":["S104453232100052X"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2021.101521","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and molecular diversity in spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2021.101521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101521"}}